Verily and Dexcom are developing miniaturized continuous glucose monitors (CGM) to help people with Type 2 diabetes better manage the condition. Verily and Dexcom are focused on minimizing the cost and size of CGM to enable more people to control their diabetes with timely, actionable information. Verily is building miniaturized sensor electronics on an adhesive patch to make continuous monitoring less disruptive. Smaller and more comfortable CGMs may replace finger sticks in people with Type 2 diabetes, and have the potential to increase behavioural compliance and adherence to treatment regimes.
News items and features like this appear in the Desang Diabetes Magazine, our free-to-receive digital journal (see below, or www.desang-magazine.co.uk). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it’s free, and you can easily unsubscribe should you wish to).
